Composition for and method of reducing low density lipoprotein cholesterol concentration
AssigneeProtein Technologies International, Inc.
InventorsDoyle H. Waggle, Susan M. Potter, Edna C. Henley
Life of this patent
Estimating the term…
Loading patent…
AssigneeProtein Technologies International, Inc.
InventorsDoyle H. Waggle, Susan M. Potter, Edna C. Henley
Estimating the term…
The present invention is a composition comprising a plant sterol and a soy protein material and/or and isoflavone selected from genistein, daidzein, glycitein, biochanin A, formononetin, and their naturally occurring glycosides, where the plant sterol comprises at least 0.49% of the composition, by weight. The present invention is also a method for decreasing the blood concentration of total and LDL cholesterol in a human in which a plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.49%, by weight, of the combined weight of the plant sterol and the soy protein material and/or the isoflavone. The present invention is also a method for preventing or minimizing the development of atherosclerosis in a human in which a plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.49%, by weight, of the combined weight of the plant sterol and the soy protein material and/or the isoflavone.
A composition, comprising:
A method for lowering blood concentration of total and low density lipoprotein cholesterol in a human, comprising:
A method for preventing or minimizing the development of atherosclerosis, comprising:
A composition, comprising:
A method for lowering blood concentration of total and low density lipoprotein cholesterol in a human, comprising:
A method for preventing or minimizing the development of atherosclerosis, comprising,
A composition, comprising:
A method for lowering blood concentration of total and low density lipoprotein cholesterol in a human, comprising:
A method for preventing or minimizing the development of atherosclerosis, comprising co-administering a plant sterol and an isoflavone selected from the group consisting of genistein, daidzein, glycitein, biochanin A, formononetin, and their naturally occurring glycosides and glycoside conjugates to said human to prevent or minimize the development of atherosclerosis, where said plant sterol comprises at least 0.49%, by weight, of the combined weight of the co-administered plant sterol and isoflavone.
A composition, comprising:
A method for lowering blood concentration of total and low density lipoprotein cholesterol in a human comprising:
Dependencies are inferred from the claim text.